Austin, Texas, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Digital Brands Group, Inc. (NASDAQ:DBGI) (the “Company,” “Digital Brands Group” or “DBG”) today announced a new partnership with Aha (formerly HeadAI), an AI-powered influencer marketing platform with a global network of more than 50 million creators. The collaboration strengthens the Company’s technology roadmap and supports both its consumer brands and its expanding collegiate division. Digital Brands Group operates a multi-segment platform spanning lifesty ...

MARLBOROUGH, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) -- ConnectM Technology Solutions, Inc. (OTC: CNTM) (“ConnectM” or the “Company”), a constellation of technology-driven businesses powering the modern energy economy, today released its 2025 annual shareholder letter, highlighting its progress in moving from a roughly $50 million stockholders’ deficit to positive equity, restoring OTCQB trading status, delivering strong year-over-year revenue growth, and advancing its Keen Labs Energy Intelligence Network th ...

Core Insights - Ernexa Therapeutics announced promising preclinical results for its lead cell therapy candidate, ERNA-101, showing significant survival benefits and immune activation in ovarian cancer models [1][5] - The proprietary platform utilizes induced pluripotent stem cells (iPSCs) to create induced mesenchymal stem cells (iMSCs), which can effectively reprogram immunosuppressive tumor microenvironments into immune-active states [2][4] Company Overview - Ernexa Therapeutics is focused on developing innovative cell therapies for advanced cancer and autoimmune diseases, leveraging a scalable, off-the-shelf approach that does not require patient-specific cell harvesting [7][6] - The company’s lead product, ERNA-101, aims to enhance the immune system's ability to recognize and attack cancer cells, with a specific initial focus on ovarian cancer [8][9] Research Findings - The preclinical study demonstrated that iMSCs engineered to secrete interleukin-7 (IL-7) and interleukin-15 (IL-15) produced cytokine levels approximately 20-fold higher than those reported in engineered T-cell approaches, leading to robust T-cell expansion and activation [4][5] - In an ovarian cancer model, the administration of IL-7/IL-15-secreting iMSCs resulted in significant immune cell infiltration, macrophage polarization towards a pro-inflammatory phenotype, and prolonged survival, indicating a shift from an immune-excluded to a highly inflamed tumor microenvironment [5][6] Future Directions - The company plans to advance ERNA-101 through additional preclinical testing, with first-in-human trials anticipated for the following year [6][4] - Ernexa Therapeutics views the ability to manufacture clonal, gene-modified cells at scale as a competitive advantage in the clinical development of its therapies [4]

Navitas, Cyient Semiconductors Enter into a Strategic Partnership to Accelerate GaN Adoption in India’s AI, Mobility, Industrial, and Energy Markets The partnership seeks to build a robust local supply chain and manufacturing ecosystem in support of the Indian Government’s “Make in India” initiative. In addition, through this partnership Navitas and Cyient Semiconductor aims to deploy IC technology in accelerating solution development for high voltage and high-power markets. TORRANCE, Calif. and HYDERA ...

Core Insights - American Rebel Holdings, Inc. has announced a strategic distribution partnership with Banko Beverage Company to expand the distribution of American Rebel Light Beer in Pennsylvania [1][6][17] - The partnership with Banko Beverage marks the fourth top-tier distributor in Pennsylvania and the seventh new wholesaler added in a short period, indicating rapid growth in distribution [2][5] - The company aims to leverage its distribution-first strategy to achieve full national coverage by 2026, emphasizing aggressive market penetration and partnerships with respected distributors [4][6][17] Company Overview - American Rebel Holdings, Inc. is positioned as "America's Patriotic Brand" and has expanded into the $110 billion domestic premium beer market with American Rebel Light Beer [6][16] - The beer is marketed as a premium domestic light lager with approximately 100 calories, 3.2g of carbohydrates, and 4.3% ABV per 12 oz serving, crafted without common additives found in mass-produced beers [14][15] - The company has secured distribution in 17 states and continues to grow its network through partnerships with family-owned wholesalers [15] Distributor Profile - Banko Beverage Company, founded in 1933, is a family-owned wholesaler recognized for its excellence and community involvement, servicing over 1,000 establishments across 10 counties in the Greater Lehigh Valley [7][8][13] - The company has a strong portfolio, representing iconic brands such as Miller, Yuengling, Heineken, and Guinness, and has received the MillerCoors President's Award for outstanding distributor performance [13][22] - Banko's modern facilities and logistical capabilities support efficient distribution, enhancing American Rebel Light Beer’s market presence in Pennsylvania [8][22] Market Strategy - The company’s distribution-first strategy is gaining momentum, with significant leads generated from the 2025 NBWA Convention, resulting in rapid conversion to signed partnerships [4][5] - American Rebel is focused on executing its strategy to dominate the Pennsylvania market, with a clear intent to expand aggressively into other states [6][17] - The brand's patriotic positioning aligns with community values, enhancing its appeal and marketability [22]

Leronlimab treatment is associated with upregulation of PD-L1 in circulating tumor cells and cancer-associated macrophage-like cells Remarkably longer survival was observed in patients treated with leronlimab in combination with or followed by an immune checkpoint inhibitor VANCOUVER, Washington, Dec. 08, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 r ...

Revenue through Nine Months Down 27.0% to $173.5 MillionNet Income through Nine Months is $9.6 MillionKey Balance Sheet Metrics Continue to Improve as Current Ratio Reaches 3.98Backlog Pulls Nearly Even on YOY Basis as Order Rates Begin to StabilizeBoard Declares Quarterly Cash Dividend of $0.025 per Share, Payable January 9, 2026 to Shareholders of Record as of December 19, 2025 TORRANCE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Virco Mfg. Corporation (NASDAQ: VIRC), a leading manufacturer and supplier of ...

Investigator-Initiated Preclinical studies at CIC biomaGUNE aimed at combatting Glioblastoma Multiforme Research will evaluate effects of intra-arterial delivery of Annamycin HOUSTON, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viral infections, today announced it has entered into a research and material transfer agreement with CIC ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE PUBLICATION, DISTRIBUTION OR DISSEMINATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. TORONTO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (“Dundee” or the “Corporation”) is pleased to announce that it has entered into an agreement with BMO Capital Markets Inc. and SCP Resource Finance LP (together, the “Dealers”) to sell 24,480,000 units (the “Units”) at a price of C$4.00 per Unit to ...

Core Viewpoint - American Rare Earths has appointed Mark Wall as the new CEO, effective January 5, 2026, to lead the company in its transition from an explorer to a U.S. producer of rare earth elements [1][2]. Company Developments - Mark Wall brings over 30 years of global mining experience, including senior leadership roles in major mining companies, which aligns with the company's goals [2]. - The company has achieved significant milestones, including an upgraded mineral resource estimate for the Cowboy State Mine and advancements in impurity removal processes [3]. - American Rare Earths is advancing a pre-feasibility study and planning a demonstration plant to validate its processing flowsheet [4][5]. Strategic Focus - Under Wall's leadership, the company will focus on completing the Halleck Creek prefeasibility study, advancing the demonstration plant, and leveraging relationships for non-dilutive funding opportunities [5][6]. - The company is also preparing for a potential U.S. listing to broaden its investor base and reflect its U.S. project footprint [5][6]. Project Significance - The Halleck Creek project is positioned to reduce U.S. reliance on rare earth imports, particularly from China, and is essential for national defense and economic security [9]. - The project benefits from cost-efficient open-pit mining methods and streamlined permitting processes in Wyoming, enhancing its potential for securing America's critical mineral independence [8][9].